Latest company, clinical, regulatory and partnership updates from Fibralign.
Fibralign announced that Medel Tıp has assumed exclusive distribution for BioBridge Collagen Matrix in Turkey.
Read full newsFibralign and leading physicians presented an update on clinical findings and case studies during the ISL World Congress.
Read more →Fibralign Corp. and leading physicians presented an update on clinical findings and case studies during the 30th World Congress of the International Society of Lymphology.
Read more →Good Moonwha Hospital completed its 100th BioBridge case in the surgical treatment of lymphedema.
Read more →Good Moonwha Hospital completed its 100th BioBridge case in the surgical treatment of lymphedema.
Read more →The first clinical trial conducted in Japan for evaluation of BioBridge reached its endpoint.
Read more →The first clinical trial conducted in Japan to evaluate BioBridge in the surgical treatment of lymphedema reached its endpoint.
Read more →BioBridge Collagen Matrix received Korean regulatory approval as an Absorbable Implantable Mesh.
Read more →Fibralign entered into an agreement with Healing Solutions to serve as exclusive distributor in South Korea.
Read more →Fibralign hosted an international research seminar focused on advancements in lymphedema surgical treatment.
Read more →